Gain Therapeutics Inc. (GANX)
NASDAQ: GANX
· Real-Time Price · USD
1.73
0.19 (12.34%)
At close: Aug 15, 2025, 3:59 PM
1.76
1.73%
After-hours: Aug 15, 2025, 07:49 PM EDT
Gain Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 6.69M | 9.07M | 10.39M | 12.05M | 16.94M | 10.64M | 11.79M | 4.27M | 6.32M | 5.99M | 7.31M | 10.88M | 14.31M | 34.34M | 36.88M | 40.98M | 43.16M | 46.59M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | 2.02M | 5M | 7.96M | 9.87M | 11.83M | 12.83M | 11.85M | 9.94M | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 36.28K | 32.54K | 31.7K | 33.87K | 31.8K | 31.74K | 34.02K | 31.14K | 31.82K | 988.39K | 1.94M | 2.92M | 4.92M | 30.86K | 31.28K | 30.87K | 31.1K | 31.55K |
Other Long-Term Assets | 161.61K | 32.64K | 32.11K | 33.01K | 17.55K | 17.61K | 17.89K | 48.5K | 49.55K | 48.78K | 48.32K | 44.66K | 46.37K | 48.06K | 53.39K | 117.87K | 130.38K | 71.75K |
Receivables | 317.84K | 886.62K | 765.76K | 373.73K | 313.25K | 249.13K | 242.58K | 101.91K | 160.73K | n/a | 87.43K | 101.92K | 227.58K | 94.86K | 195.45K | 98.57K | 450.34K | 71.45K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -113.59K | n/a | n/a | n/a |
Other Current Assets | 2.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 103.88K | 66.47K | n/a | 121.14K | n/a | n/a | 10.97K | 11.13K |
Total Current Assets | 9.31M | 11.15M | 11.6M | 13.74M | 18.54M | 13.86M | 17.78M | 13.24M | 17.31M | 19.32M | 21.09M | 24.35M | 25.83M | 36.39M | 37.72M | 41.55M | 44.34M | 47.38M |
Property-Plant & Equipment | 329.39K | 281.17K | 323.33K | 401.19K | 449.81K | 496.06K | 585.18K | 618.15K | 698.33K | 754.51K | 804.31K | 806.98K | 884.79K | 937.95K | 1.01M | 850.58K | 887.47K | 553.73K |
Goodwill & Intangibles | n/a | 126.29K | 134.27K | 156.26K | 158.15K | 169.25K | 193.38K | 189.24K | 204.55K | 208.91K | 213.97K | 208.33K | 207.67K | 220.51K | 202.61K | 39.33K | 19.36K | n/a |
Total Long-Term Assets | 527.28K | 472.65K | 521.41K | 624.32K | 657.31K | 714.66K | 830.46K | 855.89K | 952.43K | 2M | 3.01M | 3.98M | 6.06M | 1.21M | 1.26M | 1.01M | 1.02M | 657.04K |
Total Assets | 9.83M | 11.62M | 12.12M | 14.37M | 19.2M | 14.58M | 18.61M | 14.1M | 18.26M | 21.32M | 24.1M | 28.33M | 31.89M | 37.6M | 38.99M | 42.56M | 45.35M | 48.04M |
Account Payables | 2.71M | 2.15M | 946.26K | 1.1M | 2.05M | 1.41M | 1.32M | 1.38M | 924.39K | 2.21M | 1.63M | 1.02M | 948.9K | 2.12M | 560.48K | 789.39K | 978.39K | 881.75K |
Deferred Revenue | 22.68K | 217.84K | 252.21K | 708.03K | 710K | 914.76K | 1.12M | 1.35M | 1.07M | n/a | 55.18K | 55.18K | 80.2K | 202.03K | 266.5K | 327.69K | 370.52K | 178.42K |
Short-Term Debt | 136.32K | 113.12K | 110.18K | 118.28K | 111.05K | 110.85K | 118.8K | 109.28K | 111.64K | 109.2K | 108.14K | 101.26K | 83.75K | 86.62K | 103.83K | 86.64K | 65.47K | 44.29K |
Other Current Liabilities | 2.33M | 17.97K | 18.49K | n/a | 2.06M | 1.28M | 1.38M | 1.68M | 2.35M | 120.78K | 364.11K | 2.32M | 1.41M | 663.09K | 718.08K | 1.7M | 325.41K | 818.71K |
Total Current Liabilities | 5.2M | 5.03M | 3.91M | 4.59M | 6.52M | 5M | 4.95M | 5.76M | 5.59M | 5.15M | 4.13M | 4.33M | 3.41M | 4.22M | 2.55M | 3.58M | 2.45M | 2.33M |
Long-Term Debt | 92.85K | 314.48K | 328.33K | 376.13K | 375.35K | 396.84K | 449.05K | 434.94K | 466.64K | 478.3K | 495.26K | 484.02K | 542.26K | 560.89K | 590.47K | 620.17K | 646.66K | 678.25K |
Other Long-Term Liabilities | 848.03K | 470.86K | 443.62K | 323.27K | 298.43K | 292.49K | 307.45K | 160.51K | 174.19K | 164.57K | 157.58K | 377.78K | 376.3K | 367.43K | 329.46K | 243.61K | 235.69K | 194.47K |
Total Long-Term Liabilities | 940.89K | 815.92K | 872.99K | 861.49K | 888.47K | 930.99K | 1.08M | 1M | 1.58M | 1.03M | 1.09M | 1.33M | 1.46M | 1.55M | 1.61M | 1.44M | 1.51M | 1.25M |
Total Liabilities | 6.14M | 5.84M | 4.78M | 5.46M | 7.41M | 5.94M | 6.03M | 6.77M | 7.17M | 6.18M | 5.22M | 5.66M | 4.87M | 5.77M | 4.17M | 5.02M | 3.96M | 3.58M |
Total Debt | 229.17K | 606.86K | 653.01K | 769.41K | 807.57K | 889.62K | 1.03M | 1.04M | 1.14M | 1.21M | 1.27M | 1.27M | 1.39M | 1.5M | 1.61M | 1.45M | 1.52M | 1.22M |
Common Stock | 3.08K | 2.88K | 2.71K | 2.6K | 2.52K | 1.8K | 1.62K | 1.28K | 1.26K | 1.21K | 1.19K | 1.19K | 1.19K | 1.19K | 1.19K | 1.19K | 1.19K | 1.19K |
Retained Earnings | -81.19M | -81.19M | -81.19M | -77.43M | -72.94M | -64.8M | -60.78M | -56.06M | -51.34M | -43.65M | -38.52M | -33.84M | -29.28M | -24.2M | -20.93M | -17.71M | -13.04M | -9.49M |
Comprehensive Income | 584.08K | -119.86K | -247.55K | 242.81K | 12.46K | 21.86K | 247.24K | 90.66K | 134.32K | 96.31K | 35.63K | -296.9K | -145.57K | -114.3K | -90.64K | -112.08K | -164.12K | -156.86K |
Shareholders Equity | 3.7M | 5.78M | 7.34M | 8.91M | 11.78M | 8.64M | 12.58M | 7.33M | 11.09M | 15.14M | 18.88M | 22.66M | 27.02M | 31.83M | 34.82M | 37.55M | 41.39M | 44.46M |
Total Investments | 36.28K | 32.54K | 31.7K | 33.87K | 31.8K | 2.05M | 5.03M | 7.96M | 9.87M | 12.82M | 14.77M | 14.77M | 14.86M | 30.86K | 31.28K | 30.87K | 31.1K | 31.55K |